Brooklyn ImmunoTherapeutics
BTX
$0.58
Share price
-4.07%
Change (1 day)
N/A
Change (1 year)
Categories
Revenue for Brooklyn ImmunoTherapeutics (BTX)
Revenue in : N/A
.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Brooklyn ImmunoTherapeutics from to
Annual revenue
| Year | Revenue | Change |
|---|
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $44.62 B | inf% | 🇫🇷 France |
 Baxter BAX | $13.54 B | inf% | 🇺🇸 USA |
 Geron GERN | $1.37 M | inf% | 🇺🇸 USA |
 Genetic Technologies GENE | $0.01 B | inf% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | $15.08 B | inf% | 🇮🇱 Israel |
 Bio-Techne TECH | $1.07 B | inf% | 🇺🇸 USA |